We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Portable System for Warming Blood and IV-Fluids Reduces Hypothermia Risk in Hemorrhaging Patients

By HospiMedica International staff writers
Posted on 17 Jun 2024
Print article
Image: The °M Warmer portable blood & IV fluid warmer has received US FDA 510(k) regulatory clearance (Photo courtesy of °MEQU)
Image: The °M Warmer portable blood & IV fluid warmer has received US FDA 510(k) regulatory clearance (Photo courtesy of °MEQU)

Maintaining a normothermic temperature in patients is often challenging. Accidental hypothermia is a known risk that can lead to increased complications and extended hospital stays. One key factor contributing to accidental hypothermia is the infusion of cold blood and IV fluids. Research has shown that the infusion of one liter of saline at ambient temperature can reduce an adult’s body temperature by 0.4 degrees Celsius, whereas normothermic fluids do not have this effect. Infusing warmed blood and fluids is therefore crucial in reducing the incidence of accidental hypothermia. Now, a revolutionary system enables fast, easy, and efficient delivery of warm blood and IV fluids to patients.

°MEQU’s (Copenhagen, Denmark) °M Warmer System features a portable and user-friendly design that facilitates the warming of blood and IV fluids at any location—whether at the site of an injury, in transit, or within a hospital setting—thereby minimizing the risk of hypothermia in patients prone to bleeding. Utilizing a patented heating technology, the °M Warmer can warm IV fluids, including blood, from cold to body temperature in under 10 seconds. The system also supports a high and consistent normothermic flow of up to 150 ml/min. It includes a unique adhesive fixation mechanism that secures the warmer close to the infusion site, significantly minimizing any heat loss. This proximity and fixation substantially reduce the potential for IV access issues.

Setting up the °M Warmer System is simple and quick, taking less than 30 seconds, with safeguards to prevent assembly errors during stressful conditions. The °M Warmer stands out as the smallest and most compact system available, making it particularly suitable for use in crowded treatment areas and for easy transportation alongside a patient. Its design features a minimal priming volume of only 3.5 ml, ensuring that no valuable blood or fluids are wasted. The °M Warmer System is also maintenance-free and designed with smooth surfaces for easy cleaning. MEQU has obtained 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the °M Warmer System for both military and civilian use.

“We are proud to receive the FDA clearance, which is a major milestone for our company and the result of more than 10 years of product development,” said Ulrik Krogh Andersen, Founder & CEO of °MEQU. “With the clearance the road is paved for a strong presence in the U.S. market, and we are honored to be able to help U.S. healthcare professionals in their efforts to save lives with our °M Warmer System.”

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
Total Body Fat Analyzer

Print article


Surgical Techniques

view channel
Image: The SIRA RFA electrosurgical device designed specifically for patients undergoing breast-conserving surgery (Photo courtesy of Innoblative Designs)

Novel Electrosurgical Device Could Be a Game-Changer for Breast Cancer Treatment

Breast cancer represents a significant health issue globally, affecting women in every country. After diagnosis, patients face challenging choices about their treatment paths. One common treatment, Breast... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.